Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12269
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCharlton, S-
dc.contributor.authorLe, B H C-
dc.date.accessioned2015-05-16T01:55:48Z
dc.date.available2015-05-16T01:55:48Z
dc.date.issued2014-06-01-
dc.identifier.citationInternal Medicine Journal; 44(6): 619-20en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12269en
dc.language.isoenen
dc.subject.otherCardiovascular Diseasesen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherHypolipidemic Agents.therapeutic useen
dc.subject.otherMaleen
dc.subject.otherPalliative Care.methodsen
dc.subject.otherTerminally Ill.statistics & numerical dataen
dc.titlePolypharmacy in palliative care: optimising medications is an ongoing challenge.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternal Medicine Journalen
dc.identifier.affiliationPalliative Careen
dc.identifier.doi10.1111/imj.12451en
dc.description.pages619-20en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/24946823en
dc.type.contentTexten
dc.type.austinJournal Articleen
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Feb 6, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.